ليست عنوان مقالات لاتين Canadian universities go shopping for research scientists Canine atopic disease: the prevalence of positive intradermal skin tests at two sites in the north and south of Great Britain

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Canadian universities go shopping for research scientists

2

Canadian university publishes new rules to protect scientists

3

Canadian waters provide critical foraging habitat for leatherback sea turtles Original Research Article

4

Canadians allow targeted transfusion

5

Canadians are fighting fit, says government report

6

Canadians finally fill regulatory void with stem-cell bill

7

Canadians in Alabama: a perceptual study of dialect acquisition in adults

8

Canadians inquire into drug licensing

9

Canadians propose overhaul of research-ethics guidelines

10

Canadians still stung by WHOʹs SARS travel advisory

11

Canagliflozin-associated Peripheral Vascular Ischemia: A Case Report

12

Canal blocking strategies for hydrological restoration of degraded tropical peatlands in Central Kalimantan, Indonesia

13

Canal configuration of mandibular first premolars in an Egyptian population

14

Canal Configuration of Mesiobuccal Roots in Permanent Maxillary First Molars in Iranian Population: A Systematic Review

15

Canal of Nuck hernias

16

Canal preparation for prosthetic radial head replacement: rasping versus reaming

17

Canal surfaces in 4-dimensional Euclidean space

18

Canal Transportation and Centering Ability of ProTaper and SafeSider in Preparation of Curved Root Canals: A CBCT Evaluation

19

Canal Transportation and Centering Ability of Reciproc Blue, WaveOne Gold and ProTaper Next in Simulated Curved Canals

20

Canal Transportation and Centering Ability of Twisted File and Reciproc: A Cone-Beam Computed Tomography Assessment

21

Canal Transportation and Centering after Using PathFile and R-Pilot in Mesiobuccal Canals of Maxillary Molars Using Cone-Beam Computed Tomography

22

Canal Transportation and Centring Ability of Reciproc and Reciproc Blue With or Without Use of Glide Path Instruments: A CBCT Study

23

Canal water treatment with rapid sand filtration

24

Canaletto’s paintings open a new window on the relative sea-level rise in Venice

25

Canalicular adenoma of the hard palate: A rare case report

26

Canalicular and Naolacrimal Duct Blockage: An Ocular ide Effect Aociated With the Antineoplatic Drug -1

27

Canalicular bile formation: beyond single transporter functions

28

Canalicular fluid flow induced by bending of a long bone

29

Canalis Sinuosus Damage after Immediate Dental Implant Placement in the Esthetic Zone

30

Canalization as a non-genetic source of adaptiveness during morphogenesis: experimental evidence from analysis of reproductive development in Sorghum bicolor

31

Canalization of development and ecdysteroid timing during the last instar in lubber grasshoppers

32

Canals and Communities. Small-scale Irrigation Systems, Edited by J. Mabry, University of Arizona Press, 1996. ISBN 0816515921, pp. 273

33

Canard phenomenon for an SIS epidemic model with nonlinear incidence

34

Canard solution and its asymptotic approximation in a second-order nonlinear singularly perturbed boundary value problem with a turning point

35

Canard solutions of two-dimensional singularly perturbed systems

36

Canards and mixed-mode oscillations in a forest pest model

37

38

CANARD-WING INTERACTIONS IN SUBSONIC FLOW

39

Canary current upwelling: More or less?

40

Canary in the coalmine: Norwegian attitudes towards climate change and extreme long-haul air travel to Aotearoa/New Zealand

41

Canary islands aborigin sex determination based on mandible parameters contrasted by amelogenin analysis

42

Canataxpropellane, a novel taxane with a unique polycyclic carbon skeleton (tricyclotaxane) from the needles of Taxus canadensis

43

Canavalia ensiformis urease, Jaburetox and derived peptides form ion channels in planar lipid bilayers

44

Canavan disease: a monogenic trait with complex genomic interaction

45

Canavanine content in sword beans (Canavalia gladiata): Analysis and effect of processing

46

CaNb2O6 ceramics prepared by a reaction-sintering process

47

c-ANCA as a marker of Wegenerʹs disease

48

c-ANCA as a serological pitfall

49

C-ANCA Positive Vasculitis in a Case of Amyloidosis

50

Cancarb appoints European agents for its Thermax thermal blacks

51

CAN-catalyzed syntheses of 3,4-dihydroquinoxalin-2-amine derivatives based on isocyanides

52

CAN-catalyzed three-component reaction between anilines and alkyl vinyl ethers: stereoselective synthesis of 2-methyl-1,2,3,4-tetrahydroquinolines and studies on their aromatization

53

54

Canceling out both the real and the spectral lines

55

Canceling print serials in favor of electronic: criteria for decision making

56

Cancellable biometerics featuring with tokenised random number

57

Cancellable biometrics and annotations on BioHash

58

Cancellation among finite unary algebras Original Research Article

59

Cancellation and Focus: The Role of Shared and Unique Features in the Choice Process

60

Cancellation Conditions for Finite Two-Dimensional Additive Measurement

61

Cancellation errors in an integral for calculating magnetic field from reduced scalar potential

62

Cancellation in cyclic consecutive systems

63

Cancellation is exponentially powerful for computing the determinant

64

Cancellation of bending-induced birefringence in single-mode fibers: application to Faraday sensors

65

Cancellation of Capacitor Parasitic Parameters for Noise Reduction Application

66

Cancellation of digraphs over the direct product

67

Cancellation of elective oral and maxillofacial operations

68

Cancellation of Elective Surgeries in a Tertiary Care Hospital in North India

69

Cancellation of fine-structure splitting in quantum dots by a magnetic field

70

Cancellation of Harmonic Interference by Baseline Shifting of Wavelet Packet Decomposition Coefficients

71

Cancellation of heat effects in catalytic distillation

72

Cancellation of image crosstalk in time-sequential displays of stereoscopic video

73

Cancellation of Infrared Divergences at Finite Temperature

74

cancellation of land certificate based on the court decision in indonesian legal system

75

CANCELLATION OF MASS-LOADING EFFECTS OF TRANSDUCERS AND EVALUATION OF UNMEASURED FREQUENCY RESPONSE FUNCTIONS

76

Cancellation of operations in Saudi Arabian hospitals: Frequency, reasons and suggestions for improvements

77

Cancellation of polarized impulsive noise using an azimuth-dependent conditional mean estimator

78

Cancellation of projective modules over regular rings with comparability Original Research Article

79

Cancellation of renormalon ambiguities in the heavy quark effective theory Original Research Article

80

Cancellation of second-order intermodulation distortion and enhancement of IIP2 in common-source and common-emitter RF transconductors

81

Cancellation of Series-Loss Resistance in UWB Active Inductors using RC Feedback

82

Cancellation of Simulated Environmental Noise as a Tool for Measuring Vocal Performance During Noise Exposure

83

Cancellation of star light generated by a nearby star–planet system upon detection with a rotationally-shearing interferometer

84

Cancellation of Sudakov logarithms in radiative decays of quarkonia Original Research Article

85

Cancellation of the Heating Piston Effect by Convective Enhancement of a Cooling Piston Effect

86

Cancellation problem of preconditioning method at low Mach numbers

87

Cancellation properties for quotient divisible groups

88

Cancellation properties of products of graphs

89

Cancellation Properties of Projective Modules over Laurent Polynomial Rings Original Research Article

90

Cancellation Properties of Projective Modules over Laurent Polynomial Rings Original Research Article

91

Cancellation provisions in Australiaʹs Commonwealth-managed fisheries

92

Cancellation task in very low educated people

93

Cancellation techniques in underwater scattering of acoustic signals

94

Cancellation Theorems Related to Conjectures of Alperin and Dade

95

Cancellations in ambulatory day surgery: Ten years observational study

96

Cancellations in day-case ENT surgery

97

Cancellations in neutrinoless double beta decay and the neutrino mass matrix Original Research Article

98

Cancellative pairs of families of sets

99

CancellativeAbelianMonoids and Related Structures in Refutational Theorem Proving (Part I)

100

CancellativeAbelianMonoids and Related Structures in Refutational Theorem Proving (Part II)

101

Cancellativity properties for t-norms and t-subnorms

102

Cancelled IGF-1 trials bode ill for diabetic patients

103

Cancelling Jüttner distributions for space-like freeze-out

104

Cancelling quadratic divergences without supersymmetry Original Research Article

105

Cancelling vibrations in flexible articulated structures using non-causal inverse dynamics

106

Cancellous and cortical bone mineral density around an elastic press-fi t socket in total hip arthroplasty

107

Cancellous and cortical morselized allograft in revision total hip replacement:: A biomechanical study of implant stability

108

Cancellous bone architecture: Advantages of nonorthogonal trabecular alignment under multidirectional joint loading

109

Cancellous bone biomechanics

110

Cancellous bone lamellae strongly affect microcrack propagation and apparent mechanical properties: Separation of patients with osteoporotic fracture from normal controls using a 2D nonlinear finite element method (biomechanical stereology)

111

Cancellous bone mechanical properties from normals and patients with hip fractures differ on the structure level, not on the bone hard tissue level

112

Cancellous bone microdamage in the proximal femur: influence of age and osteoarthritis on damage morphology and regional distribution

113

Cancellous bone repair using bovine trabecular bone matrix particulates

114

Cancellous impaction and cortical strut allografting for revision shoulder arthroplasty: A case report

115

116

Cancer – Blame it all on viruses! Bladder tumours in cattle and sarcoids in horses may help us understand the relationship between some cancers and viruses

117

Cancer Risk in Pakistan Due to Natural Environmental Pollutants

118

Cancer “challenge” to limited-resource countries

119

Cancer ameliorating potential of Phyllanthus amarus: In vivo and in vitro studies against Aflatoxin B1 toxicity

120

Cancer among Farmers: A Meta-Analysis

121

Cancer and a Fatiguing Illness in Northern Nevada—A Causal Hypothesis

122

Cancer and aging: The molecular pathways

123

Cancer and Body Composition: An Association of Global Relevance

124

Cancer and comorbidity in older patients: A descriptive profile

125

Cancer and Complications of Peptic Ulcer in Type 2 Diabetes Mellitus patients at Wasit province, Iraq

126

cancer and covid-19: the synergistic burden on mental health status of patients with cancer

127

Cancer and Emotion; the Scope of Psycho‐Socio‐Oncology

128

Cancer and Emotion; The Scope of Psycho‐Socio‐Oncology: At the Time of Diagnosis

129

Cancer and Emotion; The Scope of Psycho-Socio-Oncology: At the Time of Treatment

130

Cancer and globalization

131

Cancer and HIV infection in Rwanda

132

Cancer and incontinence

133

Cancer and inflammation: A complex relationship

134

Cancer and its Treatment in Main Ancient Books of Islamic Iranian Traditional Medicine (7th to 14th Century AD)

135

Cancer and Low Levels of Plasma Cholesterol: The Relevance of Cholesterol Precursors and Products to Incidence of Cancer

136

Cancer and male infertility

137

Cancer and mutant DNA in blood plasma

138

Cancer and natural medicine: Textbook of basic science and clinical research: By John Boik, Oregon Medical Press, 1996

139

Cancer and Non-Cancer Risk of Arsenic in Drinking Water: A Case Study

140

Cancer and nonextensive statistics

141

Cancer and ovarian tissue cryopreservation

142

Cancer and psychosocial distress: frequent companions

143

Cancer and self-help: Bridging the troubled Waters of childhood illness : By Mark A. Chesler and Barbara K. Chesney. The University of Wisconsin Press, Madison, WI, 1995. 416 pp

144

Cancer and the human genome: no quick fix

145

Cancer and the meaning of work

146

Cancer and thromboembolic disease: how important is the risk of thrombosis?

147

Cancer and thromboembolic disease: pathogenic mechanisms

148

Cancer and thrombosis revisited

149

Cancer and venous thromboembolism

150

Cancer and Women’s Health

151

Cancer and wood-related occupational exposure in the Amazon region of Brazil

152

Cancer anorexia and cachexia

153

Cancer anorexia: a model for the understanding and treatment of secondary anorexia

154

Cancer anorexia: new pathogenic andtherapeutic insights

155

Cancer Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), Risk of Malignancy Index (RMI), and Risk of Ovarian Malignancy Algorithm (ROMA) as Diagnostic Tests in Ovarian Cancer

156

Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma

157

Cancer as a Complex Genetic Trait: Tumor Susceptibility in Humans and Mouse Models

158

Cancer as an Embryological Phenomenon and Its Developmental Pathways: A Hypothesis regarding the Contribution of the Noncanonical Wnt Pathway

159

Cancer associated with obstetric delivery: results of linkage with the California cancer registry

160

Cancer biology and necrotic changes in metastatic lymph nodes and survival of colon cancer patients

161

Cancer biology for the clinic and the lab

162

Cancer biomarker and neurotransmitters recognition by molecularly imprinted xero-gels

163

Cancer Biomarkers

164

Cancer biomarkers

165

Cancer biomarkers detection using 3D microstructured protein chip: Implementation of customized multiplex immunoassay

166

Cancer Biomarkers: Closer to Delivering on their Promise

167

Cancer Biopsy in Ancient Persian Medicine: Do or Not to Do!

168

Cancer bio-repository

169

Cancer bronchique localement évolué : qu’apporte la radiothérapie avec modulation d’intensité rotationnelle ?

170

Cancer bronchique localement évolué : qu’apporte la radiothérapie avec modulation d’intensité rotationnelle ?

171

Cancer bronchique non à petites cellules de l’apex pulmonaire et chimioradiothérapie de haute dose : expérience du centre hospitalier Lyon-Sud

172

Cancer bronchique non à petites cellules de l’apex pulmonaire et chimioradiothérapie de haute dose : expérience du centre hospitalier Lyon-Sud

173

Cancer bronchique non à petites cellules localement évolué : place de la chimioradiothérapie exclusive

174

Cancer bronchique non à petites cellules: mise au point en 1998

175

Cancer bronchique : le drainage lymphatique

176

Cancer burden and trends in the asian pacific RIM region

177

Cancer cachexia

178

Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation

179

Cancer Cachexia, Malnutrition, and Tissue Protein Turnover in Experimental Animals

180

Cancer Cachexia, Malnutrition, and Tissue Protein Turnover in Experimental Animals

181

Cancer cachexia: Measured and predicted resting energy expenditures for nutritional needs evaluation

182

Cancer cachexia: Metabolic alterations and clinical manifestations

183

Cancer Cancer vaccines: a road map for the next decade

184

Cancer care during the natural disasters, the lessons learned from Kermanshah Earthquake in 2017

185

Cancer Care Ontario guaiac fecal occult blood test (FOBT) laboratory standards: Evidentiary base and recommendations

186

Cancer cell detection in tissue sections using AFM

187

Cancer cell dissemination during curative surgery for colorectal liver metastases

188

Cancer Cell Dynamics in Presence of Telomerase Inhibitors: Analysis of In Vitro Data

189

Cancer Cell Invasion: Treatment and Monitoring Opportunities in Nanomedicine

190

Cancer Cell Metabolism: Warburg and Beyond

191

Cancer Cell progression

192

Cancer Cell Separation Using Passive Mechanisms: a Review

193

Cancer cell separator using size-dependent filtration in microfluidic chip

194

Cancer Cells Display Profound Intra- and Interline Variation following Prolonged Exposure to Antimitotic Drugs

195

Cancer cells isolated from malignant pleural and peritoneal effusions inhibit phospholipase A2 activity in human polymorphonuclear leukocytes

196

Cancer Cells Release a Covalent Complex Containing Disulfide-Linked Domains from Urinary Plasminogen Activator, Neural Cell Adhesion Molecule, and Haptoglobin α and β Chains

197

Cancer Cells Treated by Clusters of Copper Oxide Doped Calcium Silicate

198

Cancer chemoprevention by dietary chlorophylls: A 12,000-animal dose–dose matrix biomarker and tumor study

199

Cancer chemoprevention with garlic and its constituents

200

Cancer Chemoprevention. Vol. 2: Strategies for Cancer Chemoprevention.G.J. Kellof, E.T. Hawk and C.C. Sigman, Editors, Humana Press, Totowa (2005).

201

Cancer Chemoprevention. Volume I. Promising Cancer Chemopreventive Agents.G.J. Kelloff, E. T. Hawk and C.C. Sigman, Editors, P. Humana Press, Totowa (2004)

202

Cancer chemoprevention: A radical perspective

203

Cancer chemopreventive activity of 3,5,6,7,8,3′,4′-heptamethoxyflavone from the peel of citrus plants

204

Cancer chemopreventive activity of 3β-methoxyserrat-14-en-21β-ol and several serratane analogs on two-stage mouse skin carcinogenesis

205

Cancer chemopreventive activity of Achyranthes aspera leaves on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis

206

Cancer chemopreventive activity of acridone alkaloids on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis

207

Cancer chemopreventive activity of an iridoid glycoside, 8-acetylharpagide, from Ajuga decumbens

208

Cancer chemopreventive activity of carotenoids in the fruits of red paprika Capsicum annuum L.

209

Cancer chemopreventive activity of euglobal-G1 from leaves of Eucalyptus grandis

210

Cancer chemopreventive activity of flavanones on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis

211

Cancer chemopreventive activity of majonoside-R2 from Vietnamese ginseng, Panax vietnamensis

212

Cancer chemopreventive activity of naphthoquinones and their analogs from Avicennia plants

213

Cancer chemopreventive activity of phenylpropanoid esters of sucrose, vanicoside B and lapathoside A, from Polygonum lapathifolium

214

Cancer chemopreventive activity of phenylpropanoids and phytoquinoids from Illicium plants

215

Cancer chemopreventive activity of serratane-type triterpenoids on two-stage mouse skin carcinogenesis

216

Cancer chemopreventive activity of synthetic colorants used in foods, pharmaceuticals and cosmetic preparations

217

Cancer chemopreventive agents, 4-phenylcoumarins from Calophyllum inophyllum

218

Cancer chemopreventive agents, labdane diterpenoids from the stem bark of Thuja standishii (Gord.) Carr

219

Cancer chemopreventive agents, serratane-type triterpenoids from Picea jezoensis

220

Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives

221

Cancer chemopreventive effect of dietary Zataria multiflora essential oils

222

Cancer chemopreventive effect of orally administrated lupane-type triterpenoid on ultraviolet light B induced photocarcinogenesis of hairless mouse

223

Cancer chemopreventive effect of quassinoid derivatives. Introduction of side chain to shinjulactone C for enhancement of inhibitory effect on Epstein–Barr virus activation

224

Cancer chemopreventive effects of constituents of Caesalpinia ferrea and related compounds

225

Cancer chemopreventive effects of oral feeding α-tocopherol on ultraviolet light B induced photocarcinogenesis of hairless mouse

226

Cancer chemopreventive effects of Pinus Maritima bark extract on ultraviolet radiation and ultraviolet radiation-7,12,dimethylbenz(a)anthracene induced skin carcinogenesis of hairless mice

227

Cancer chemopreventive effects of polyunsaturated fatty acids

228

Cancer Chemo-Preventive Effects of Red Propolis: a System Biology Approach

229

Cancer chemopreventive oltipraz generates superoxide anion radical

230

Cancer Chemoprotection by Oltipraz: Experimental and Clinical Considerations

231

Cancer chemotherapy – ribonucleases to the rescue Review Article

232

Cancer Chemotherapy and Biotherapy

233

Cancer chemotherapy in the older cancer patient

234

Cancer chemotherapy optimization under evolving drug resistance Original Research Article

235

Cancer chemotherapy with indole-3-carbinol, bis(3′-indolyl)methane and synthetic analogs

236

Cancer chemotherapy, biodiversity, public and private property: the case of the anti-cancer drug Taxol

237

Cancer chemotherapy: A SN-38 (7-Ethyl-10-hydroxycamptothecin) glucuronide prodrug for treatment by a PMT (Prodrug monoTherapy) strategy

238

Cancer chez le sujet âgé : place du dépistage gériatrique dans la décision thérapeutique

239

Cancer chez le sujet âgé : place du dépistage gériatrique dans la décision thérapeutique

240

Cancer Classification in Microarray Data using a Hybrid Selective Independent Component Analysis and υ‑Support Vector Machine Algorithm

241

Cancer Classification with a Cost-Sensitive Naive Bayes Stacking Ensemble

242

Cancer Control at the Workplace: The Working Well Trial

243

Cancer Control strategy in the world, a review article

244

Cancer control: a reminder of the need for a balanced approach between prevention and treatment

245

Cancer cutané et xéroderma pigmentosum

246

Cancer cutané et xéroderma pigmentosum

247

Cancer de l’endomètre de stade I

248

Cancer de l’estomac : doses et volumes-cibles

249

Cancer de l’estomac. Le point thérapeutique en 2008

250

Cancer de la langue : expérience de l’Institut national d’oncologie de Rabat, à propos de 60 cas

251

Cancer de la langue : expérience de l’Institut national d’oncologie de Rabat, à propos de 60 cas

252

Cancer de la prostate

253

Cancer de la prostate 2010. Innovations thérapeutiques

254

Cancer de la prostate chez l’homme de moins de 50 ans : à propos de 26 cas

255

Cancer de la prostate chez l’homme de moins de 50 ans : à propos de 26 cas

256

Cancer de la prostate localisé et radiothérapie conformationnelle avec modulation d’intensité : quels sont les paramètres dosimétriques les plus pertinents pour prédire la toxicité digestive aiguë ?

257

Cancer de la prostate localisé et radiothérapie conformationnelle avec modulation d’intensité : quels sont les paramètres dosimétriques les plus pertinents pour prédire la toxicité digestive aiguë ?

258

Cancer de la prostate localisé, à risque intermédiaire ou élevé, dont le traitement a été une radiothérapie externe et incluant une curiethérapie de haut débit de dose : expérience du pôle régional de cancérologie de Poitou-Charentes

259

Cancer de la prostate localisé, à risque intermédiaire ou élevé, dont le traitement a été une radiothérapie externe et incluant une curiethérapie de haut débit de dose : expérience du pôle régional de cancérologie de Poitou-Charentes

260

Cancer de la thyroïde après exposition aux rayonnements ionisants

261

Cancer de lʹœsophage : répercussion des thérapeutiques néoadjuvantes sur la morbidité et la mortalité opératoire

262

Cancer de prostate et RCMI guidée par l’image : absence de corrélation entre paramètres dose/volume des organes à risque et toxicité tardive

263

Cancer de prostate et RCMI guidée par l’image : absence de corrélation entre paramètres dose/volume des organes à risque et toxicité tardive

264

Cancer de prostate localisé. Que dire au patient ?

265

Cancer de prostate : doses et volumes cibles

266

Cancer death epidemics in United States Black males: Evaluating courses, causation, and cures

267

CANCER DEATH RATES AND BACKGROUND RADIATION

268

Cancer detection and mammogram volume of radiologists in a population-based screening programme

269

Cancer detection from textual data using a combination of machine learning approach

270

Cancer Detection Using Aritifical Neural Network and Support Vector Machine: A Comparative Study

271

Cancer Development and Electromagnetic Fields in Near Future

272

Cancer diagnosis by autofluorescence of blood components

273

Cancer Diagnosis Disclosure: What is the Right Thing to Do?

274

Cancer Diagnosis in Endoscopic Images using Discrete Wavelet Transform

275

Cancer diagnosis, treatment, and survival in Indigenous and non-Indigenous Australians: a matched cohort study

276

Cancer Disclosure in Iran: Attitude of Patients and Their Families

277

Cancer disclosure in Japan: Historical comparisons, current practices

278

Cancer distress screening: Needs, models, and methods

279

Cancer dose–response assessment for acrylonitrile based upon rodent brain tumor incidence: Use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity

280

Cancer driver mutations in protein kinase genes

281

Cancer du canal anal : expérience de l’Institut national d’oncologie de Rabat, à propos de 110 cas

282

Cancer du canal anal : expérience de l’Institut national d’oncologie de Rabat, à propos de 110 cas

283

Cancer du cavum au centre tunisien : à propos de 525 cas

284

Cancer du cavum au centre tunisien : à propos de 525 cas

285

Cancer du cavum chez le sujet jeune

286

Cancer du cavum chez le sujet jeune

287

Cancer du cavum chez les sujets âgés : expérience d’un centre tunisien

288

Cancer du cavum chez les sujets âgés : expérience d’un centre tunisien

289

Cancer du cavum dans l’ouest algérien : à propos de 578 cas traités à Oran, Algérie

290

Cancer du cavum dans l’ouest algérien : à propos de 578 cas traités à Oran, Algérie

291

Cancer du cavum dans la région de Marrakech. Expérience du service d’oncologie du centre hospitalier universitaire Mohammed-VI de Marrakech

292

Cancer du cavum dans la région de Marrakech. Expérience du service d’oncologie du centre hospitalier universitaire Mohammed-VI de Marrakech

293

Cancer du cavum dans le centre tunisien : facteurs pronostiques

294

Cancer du cavum dans le centre tunisien : facteurs pronostiques

295

Cancer du cavum du sujet âgé

296

Cancer du cavum du sujet âgé

297

Cancer du cavum et syndromes paranéoplasiques

298

Cancer du cavum et syndromes paranéoplasiques

299

Cancer du col utérin

300

Cancer du col utérin chez la femme jeune : à propos de 96 cas au Centre d’oncologie du CHU Ibn Rochd de Casablanca

301

Cancer du col utérin chez la femme jeune : à propos de 96 cas au Centre d’oncologie du CHU Ibn Rochd de Casablanca

302

Cancer du col utérin stades IB et II opérable : comparaison rétrospective entre curiethérapie utérovaginale préopératoire et chirurgie première suivies d’une radiothérapie

303

Cancer du col utérin : expérience du Maroc, à propos de 696 cas

304

Cancer du col utérin : expérience du Maroc, à propos de 696 cas

305

Cancer du larynx chez le sujet âgé

306

Cancer du larynx chez le sujet âgé

307

Cancer du larynx : expérience de l’institut national d’oncologie de Rabat, à propos de 404 cas

308

Cancer du larynx : expérience de l’institut national d’oncologie de Rabat, à propos de 404 cas

309

Cancer du nasopharynx chez l’enfant et l’adolescent : expérience du service de radiothérapie et d’oncologie Ibn-Rochd de Casablanca

310

Cancer du nasopharynx chez l’enfant et l’adolescent : expérience du service de radiothérapie et d’oncologie Ibn-Rochd de Casablanca

311

Cancer du nasopharynx dans l’Ouest algérien : résultats à long terme et facteurs pronostiques dans une cohorte de 200 cas

312

Cancer du nasopharynx dans l’Ouest algérien : résultats à long terme et facteurs pronostiques dans une cohorte de 200 cas

313

Cancer du pancréas localement évolué non resécable : chimioradiothérapie d’induction suivie de chimiothérapie par gemcitabine contre chimiothérapie exclusive par gemcitabine : résultats définitifs de l’étude de phase III 2000–2001de la FFCD et de la SFRO

314

Cancer du rectum avec métastases synchrone

315

Cancer du rectum avec métastases synchrone

316

Cancer du rectum chez le sujet de moins de 40 ans

317

Cancer du rectum chez le sujet de moins de 40 ans

318

Cancer du rectum localement évolué : place du boost tumoral en chimioradiothérapie concomitante préopératoire, étude rétrospective portant sur 75 cas

319

Cancer du rectum localement évolué : place du boost tumoral en chimioradiothérapie concomitante préopératoire, étude rétrospective portant sur 75 cas

320

Cancer du rectum : volumes cibles de la radiothérapie préopératoire

321

322

Cancer du sein bilatéral après maladie de Hodgkin. Particularités clinico-histologiques et possibilités thérapeutiques: analyse de 13 cas

323

Cancer du sein chez la femme âgée

324

Cancer du sein chez la femme âgée

325

Cancer du sein chez la femme âgée de plus de 70 ans : expérience de l’Institut national d’oncologie de Rabat

326

Cancer du sein chez la femme âgée de plus de 70 ans : expérience de l’Institut national d’oncologie de Rabat

327

Cancer du sein chez la femme de moins de 40 ans dans la région de Marrakech

328

Cancer du sein chez la femme de moins de 40 ans dans la région de Marrakech

329

Cancer du sein chez la femme jeune au Maroc

330

Cancer du sein chez la personne âgée : place de la radiothérapie ?

331

Cancer du sein chez la personne âgée : place de la radiothérapie ?

332

Cancer du sein d’emblée métastatique : impact de l’irradiation locorégionale exclusive sur la survie globale

333

Cancer du sein d’emblée métastatique : impact de l’irradiation locorégionale exclusive sur la survie globale

334

Cancer du sein de la femme de moins de 35 ans

335

Cancer du sein de la femme de moins de 35 ans

336

Cancer du sein et radiothérapie peropératoire par électrons : revue des 100 premières patientes traitées à l’institut Jules-Bordet

337

Cancer du sein et radiothérapie peropératoire par électrons : revue des 100 premières patientes traitées à l’institut Jules-Bordet

338

Cancer du sein et ultrasons : de l’imagerie au traitement des cancers

339

Cancer du sein et ultrasons : de l’imagerie au traitement des cancers

340

Cancer du sein inflammatoire au centre hospitalier universitaire Hassan-II de Fès : à propos de 41 cas

341

Cancer du sein inflammatoire au centre hospitalier universitaire Hassan-II de Fès : à propos de 41 cas

342

Cancer du sein localement évolué non inflammatoire traité par association de chimiothérapie et de radiothérapie à dose préopératoire : réactualisation des résultats d’une série de 120 patientes

343

Cancer du sein métastatiques : intérêt du CA 15-3

344

Cancer du sein métastatiques : intérêt du CA 15-3

345

Cancer du sein négligé et localement évolué : quelle réalité ? Réflexion à propos de deux cas sur l’optimisation de la prise en charge multidisciplinaire

346

Cancer du sein secondaire chez l’homme après traitement pour maladie de Hodgkin. À propos d’un cas et revue de la littérature

347

Cancer du sein traité exclusivement par l’association d’une irradiation externe et d’une curiethérapie exclusive : résultats à long terme

348

Cancer du sein : comparaison dosimétrique entre la technique des filtres en coin et celle « champ dans le champ »

349

Cancer du sein : comparaison dosimétrique entre la technique des filtres en coin et celle « champ dans le champ »

350

Cancer du sein. Questions et réponses au quotidien, J Saglier, EC Antoine. Masson, New York (1996), 125

351

Cancer du canal anal : comparaison dosimétrique entre radiothérapie trimensionnelle classique et par modulation d’intensité

352

Cancer du canal anal : comparaison dosimétrique entre radiothérapie trimensionnelle classique et par modulation d’intensité

353

Cancer education among primary care physicians in an underserved community

354

Cancer epidemiology and trends in Sistan and Baluchestan province, Iran

355

Cancer Epidemiology in Lebanon

356

Cancer Epidemiology in Radiation Oncology: An Institutional Experience From North India During 2016-2022

357

Cancer Epidemiology: The International Journal of Cancer Epidemiology, Detection and Prevention

358

Cancer epigenetics as biomarkers of clinical significance

359

Cancer epigenetics is no Mickey Mouse

360

Cancer epigenetics is no Mickey Mouse

361

Cancer Epigenetics: From Mechanism to Therapy

362

CANCER ESOPHAGUS: AN AUDIT OF CURRENT MANAGEMENT FOR YEMENI PATIENTS

363

Cancer Events After Acute or Chronic Exposure to Sulfur Mustard: A Review of the Literature

364

Cancer experts square up for European funds

365

Cancer familiarity status in patients with early brest cancer: Our experience

366

Cancer fatalism among african-americans: A review of the literature

367

Cancer Feature Selection and Classification Using a Binary Quantum-Behaved Particle Swarm Optimization and Support Vector Machine

368

Cancer gene may move quickly into skin clinics

369

Cancer gene therapy targeting cellular apoptosis machinery

370

Cancer genes and molecular oncology in the clinic

371

Cancer gene-therapy: clinical trials

372

Cancer Genetics and Cytogenetics

373

Cancer Genetics and Epigenetics: Two Sides of the Same Coin?

374

Cancer genetics and genomics of human FOX family genes

375

Cancer Genetics and the Cardiotoxicity of the Therapeutics

376

Cancer genome sequencing: Understanding malignancy as a disease of the genome, its conformation, and its evolution

377

Cancer Genomes Evolve by Pulverizing Single Chromosomes

378

Cancer genomics

379

Cancer Genomics: The Road Ahead

380

Cancer groups meet in Edinburgh

381

cancer has an independent association with death in hospitalized patients with covid-19: a single-center study in iran

382

Cancer hazard identification and qualitative risk assessment

383

Cancer heterogeneity and “The Struggle for Existence”: Diagnostic and analytical challenges

384

Cancer hopes and setbacks

385

Cancer immunomics: Using autoantibody signatures in the early detection of prostate cancer

386

Cancer immunoprevention: tracking down persistent tumor antigens

387

Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?

388

Cancer immunotherapy – broader considerations

389

Cancer Immunotherapy Using Microfluidic Systems

390

Cancer immunotherapy, mathematical modeling and optimal control

391

Cancer immunotherapy: novel strategies and clinical experiences

392

Cancer immunotherapy: simply cell biology?

393

Cancer immunotherapyʹs renaissance

394

Cancer in home care: Unintended weight loss and ethical challenges. A cross-sectional study of older people at 11 sites in Europe

395

Cancer in Kenya: types and infection-attributable. Data from the adult population of two National referral hospitals (2008-2012)

396

Cancer in Korean War Navy Technicians: Mortality Survey after 40 Years

397

Cancer in Lebanon: An Epidemiological Review of the American University of Beirut Medical Center Tumor Registry (1983–1994)

398

Cancer in married couples: Higher or lower distress?

399

Cancer in Maysan: Mortality, Pattern, and Demographic Characteristics during the Last 4 Decades

400

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study Original Research Article

401

Cancer in patients on renal replacement therapy in Lombardy, Italy

402

Cancer in people with depression or anxiety: record-linkage study

403

Cancer in pregnancy: Gaps, challenges and solutions

404

Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study

405

Cancer in the mass print media: Fear, uncertainty and the medical model

406

Cancer in the older person

407

Cancer in the Sudan: An overview of the current status of knowledge on tumor patterns and risk factors Original Research Article

408

Cancer incidence among Danish Seventh-day Adventists and Baptists

409

Cancer incidence among Mormons and non-Mormons in Utah (United States) 1995–1999

410

Cancer incidence among pesticide applicators exposed to trifluralin in the Agricultural Health Study

411

Cancer incidence among refinery and petrochemical employees in Louisiana, 1983–1999

412

Cancer Incidence among the Elderly Population in the Northwest of Iran: A Population Based Study

413

Cancer incidence and asbestos in drinking water, Town of Woodstock, New York, 1980–1998

414

Cancer incidence and mortality after radioiodine treatment for hyperthyroidism

415

Cancer incidence and mortality after radioiodine treatment for hyperthyroidism

416

Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study

417

Cancer Incidence and Mortality in Ardabil: Report of an Ongoing Population-Based Cancer Registry in Iran, 2004-2006

418

Cancer incidence and mortality in people aged less than 75 years: Changes in Australia over the period 1987–2007

419

Cancer Incidence and Prevalence in Isfahan: Application of Mortality Data to Estimates and Projects for the Period 2001-2015

420

Cancer Incidence and Trend Analysis in Shahroud, Iran, 2000 – 2010

421

Cancer Incidence around an Oil Refinery as an Example of a Small Area Study Based on Map Coordinates

422

Cancer incidence estimation at a district level without a national registry: A validation study for 24 cancer sites using French health insurance and registry data

423

Cancer incidence in a petrochemical industry area in Sweden Original Research Article

424

Cancer incidence in children conceived with assisted reproduction technology

425

Cancer incidence in Dutch Balkan veterans

426

Cancer incidence in ethnic German migrants from the Former Soviet Union in comparison to the host population

427

Cancer Incidence in Golestan Province: Report of an Ongoing Population-based Cancer Registry in Iran between 2004 and 2008

428

Cancer incidence in Jordan, 1996–2005

429

Cancer Incidence in Montana: Rates for American Indians Exceed Those for Whites Original Research Article

430

Cancer incidence in people with hepatitis B or C infection: A large community-based linkage study

431

Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998

432

Cancer Incidence in South East of Iran: Results of a Population-Based Cancer Registry

433

Cancer Incidence in Tehran Metropolis: The First Report from the Tehran Population-Based Cancer Registry, 1998 – 2001

434

Cancer incidence in the USA could double by 2050, report predicts

435

Cancer incidence in women exposed to DES in utero

436

Cancer Incidence Rate in the Elderly Inhabitants of Tehran: Is there Really any Cluster?

437

Cancer incidence rate ratios of Turkish immigrants in Hamburg, Germany: A registry based study

438

Cancer Incidence Rates among Iranian immigrants in Sweden, a Population-Based Retrospective Cohort Study

439

Cancer Incidence, Mortality and Survival in Türkiye as of 2020

440

Cancer indifférencié du cavum type : états des lieux dans le service de radiothérapie du centre hospitalier universitaire d’Oran

441

Cancer indifférencié du cavum type : états des lieux dans le service de radiothérapie du centre hospitalier universitaire d’Oran

442

Cancer indifférencié du cavum : aspects épidémiologiques, cliniques et thérapeutiques

443

Cancer indifférencié du cavum : aspects épidémiologiques, cliniques et thérapeutiques

444

Cancer Induced Infertility and the Role of L-Carnitine: A Review for Possible Future Clinical Applications

445

Cancer informatics by prototype networks in mass spectrometry

446

Cancer Information Service-Initiated Outcalls to Promote Screening Mammography among Low-Income and Minority Women: Design and Feasibility Testing, ,

447

Cancer initiation by fumonisin B1 in rat liver – role of cell proliferation

448

Cancer Invasion and the Microenvironment: Plasticity and Reciprocity

449

Cancer Is to Embryology as Mutation Is to Genetics: Hypothesis of the Cancer as Embryological Phenomenon

450

Cancer letters special issue hepatocellular carcinoma featuring the guest editors

451

Cancer Letters special issue inflammation and gastrointestinal and liver cancers featuring the guest editor

452

Cancer Letters. Featuring the guest editors: Wael M. ElShamy and Roy J. Duhé

453

Cancer magnitude, challenges and control in the Eastern Mediterranean Region

454

Cancer marker detection in human serum with a point-of-care low-cost system

455

Cancer metabolism and the dynamics of metastasis

456

Cancer Metabolism and Tumor Heterogeneity: Imaging Perspectives Using MR Imaging and Spectroscopy

457

Cancer Metabolism: Is Glutamine Sweeter than Glucose?

458

Cancer metastasis at a glance: A brief view of Breast Cancer Brain Metastasis

459

Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells

460

Cancer mode of action, weight of evidence, and proposed cancer reference value for hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)

461

Cancer Modeling and Simulation, L. Preziosi (Ed.). Chapman and Hall/CRC (2003)

462

Cancer Modeling in the Modern Era: Progress and Challenges

463

Cancer Molecular Analysis Project: Weaving a rich cancer research tapestry

464

Cancer molecules reveal their mechanisms

465

Cancer morbidity in subjects occupationally exposed to high frequency (radiofrequency and microwave) electromagnetic radiation

466

Cancer mortality among agricultural workers from Serrana Region, state of Rio de Janeiro, Brazil

467

Cancer mortality among workers in formaldehyde industries

468

Cancer mortality among workers in the meat department of supermarkets : E. S. Johnson, Occupational and Environmental Medicine, 51(8), 541–547

469

Cancer mortality and occupational exposure to aromatic amines and inhalable aerosols in rubber tire manufacturing in Poland

470

Cancer mortality and offset printing

471

Cancer mortality and prevention in the European Union

472

Cancer mortality around French nuclear sites

473

Cancer mortality in Basrah: a household survey results

474

Cancer nanomedicine: A review on approaches and applications towards targeted drug delivery

475

Cancer nanomedicines targeting tumor extracellular pH

476

Cancer nanomedicines: So many papers and so few drugs!

477

Cancer nanotechnology

478

Cancer nanotechnology

479

Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

480

Cancer Nursing: Care in Context: Jessica Corner, Christopher Bailey (Eds.); Blackwell Science, Oxford, 2001, ISBN 0-632-03998-1

481

Cancer Occurrence in Fars Province, Southern Iran

482

Cancer Occurrence in the Elderly: Agreement between Three Major Data Sources

483

Cancer of children in Basrah-Iraq: Person and time characteristics

484

Cancer of Male Urethra: Case Series and Review of Literature

485

Cancer of the breast, fifth edition.: William L. Donegan and John S. Spratt publisher: Saunders, Philadelphia, pages: 1,025. price: $179.00

486

Cancer of the breast: Is radiation therapy curative

487

Cancer of the Colon and Rectum in California: Trends in Incidence by Race/Ethnicity, Stage, and Subsite,

488

Cancer of the esophagus: histopathological sub-types in northern Uganda

489

Cancer of the gastric cardia

490

Cancer of the gastrointestinal tract results in a restricted T-cell repertoire dependent upon tumor differentiation

491

Cancer of the larynx in females

492

Cancer of the larynx in Hong Kong: a clinico-pathological study

493

Cancer of the pharynx and larynx

494

Cancer of the rectum—palliative endoscopic treatment

495

Cancer of unknown primary origin: a decade of experience in a community-based hospital

496

Cancer of unknown primary patients with midline nodal distribution: Midway between poor and favourable prognosis?

497

Cancer omics: From regulatory networks to clinical outcomes

498

Cancer onset and progression: A genome-wide, nonlinear dynamical systems perspective on onconetworks

499

Cancer pain relief achieved in mice with proenkephalin-expressing herpes vector

500

Cancer pain relief, 2nd Edn : WHO, Geneva. £11.90, ISBN 92 4 154482 1

501

Cancer Pain; Physical Factors affecting Pain Experience

502

Cancer paper retracted

503

Cancer patient advocacy: New opportunities for treatment advances

504

Cancer patient survival in Estonia 1995–2009: Time trends and data quality

505

Cancer patients and loneliness: A systematic review

506

Cancer patients desire for information: a study in a teaching hospita l in Saudi Arabia

507

Cancer patients overestimate survival chances

508

Cancer patients' satisfaction with communication and information given by nurses at teaching hospitals of Tehran, Iran

509

Cancer patientsʹ satisfaction with physicians: Princess Margaret hospital satisfaction with doctor questionnaire results

510

Cancer Patients Who Elect Euthanasia as an Option: An Argumentative Essay

511

Cancer Patients’ Challenges During COVID-19 Pandemic: An Approach to Decision-Making in Management and Policy-Making i

512

Cancer Patients’ Perceptions of Family Psychological Support: A Qualitative Study

513

Cancer Patients’ Perceptions of Family Psychological Support: A Qualitative Study

514

Cancer patients’ reluctance to discuss psychological distress with their physicians was not associated with underrecognition of depression by physicians: A preliminary study

515

Cancer pattern and survival in a rural district in South India

516

Cancer prevention

517

Cancer Prevention - Behavior Changes: The Short and the Long of It

518

Cancer prevention – the potential for diet to modulate molecular signalling

519

Cancer Prevention & Control Strategy: Resolution adopted by the 58th World Health Assembly, Geneva, May 25, 2005

520

Cancer Prevention Among Urban Southwestern American Indian Women: Comparison to Selected Year 2000 National Health Objectives

521

Cancer prevention by carotenoids

522

Cancer prevention by food factors through targeting signal transduction pathways,

523

Cancer Prevention by Protease Inhibitors

524

Cancer prevention by tocopherols and tea polyphenols

525

Cancer prevention in primary care: Predictors of patient counseling across four risk behaviors over 24 months

526

Cancer prevention in rural primary care: An academic-practice partnership

527

Cancer prevention studies: Past, present, and future directions

528

Cancer prevention studies—Past, present, and future directions

529

Cancer prevention trials and primary care physicians: Factors associated with recommending trial enrollment

530

Cancer Prevention: Chemoprevention vs Dietary Modifications

531

Cancer prevention: epidemiology and experiment

532

Cancer Prevention; Cancer Risk Management

533

Cancer Prevention; Emerging Infectious Diseases as Risk Factors, Iran Feature

534

Cancer preventive agents, Part 2: Synthesis and evaluation of 2-phenyl-4-quinolone and 9-oxo-9,10-dihydroacridine derivatives as novel antitumor promoters Original Research Article

535

Cancer preventive agents. Part 1: Chemopreventive potential of cimigenol, cimigenol-3,15-dione, and related compounds Original Research Article

536

Cancer preventive effects of flavonoids—a review

537

Cancer preventive potential of trichothecenes from Trichothecium roseum Original Research Article

538

Cancer preventive properties of ginger: A brief review

539

Cancer preventive screening: A cross-border comparison of United States and Canadian Chinese women

540

Cancer procoagulant and blood platelet activation

541

Cancer progression and p53

542

Cancer progression is associated with increased expression of basement membrane proteins in three-dimensional in vitro models of human oral cancer

543

Cancer prostatique localisé traité par irradiation conformationnelle avec modulation dʹintensité avec ou sans repositionnement échographique : la dose reçue est-elle équivalente à la dose prescrite ?

544

Cancer prostatique localisé traité par irradiation conformationnelle avec modulation dʹintensité avec ou sans repositionnement échographique : la dose reçue est-elle équivalente à la dose prescrite ?

545

Cancer proteomics: from signaling networks to tumor markers

546

Cancer proteomics: from signaling networks to tumor markers

547

Cancer radio induit par la radiothérapie des carcinomes nasopharyngés : à propos de huit cas

548

Cancer radio induit par la radiothérapie des carcinomes nasopharyngés : à propos de huit cas

549

Cancer rectocolique chez le sujet jeune

550

Cancer rectocolique chez le sujet jeune

551

Cancer Registry in Iran: a Brief Overview

552

Cancer related factors do not explain the quality of life scores for childhood cancer survivors analysed with two different generic HRQL instruments

553

Cancer Related Fears in Iranian Patients, a Survey from South East of Iran

554

Cancer related inflammation: The macrophage connection

555

Cancer research priorities for early diagnosis in Iran: Analyses based on Multiple-Attribute Decision Making Model

556

Cancer Research Studies in Native Hawaiians and Pacific Islanders

557

Cancer Research UK looks to NCI forsuccess

558

Cancer researchers get down to arrays at AACR

559

Cancer Resection on the Residual Lung After Pneumonectomy for Bronchogenic Carcinoma

560

Cancer responds better to combined treatments

561

Cancer risk above 1 Gy and the impact for space radiation protection Original Research Article

562

Cancer risk after a hospital discharge diagnosis of endometriosis, , ,

563

Cancer risk after non-melanoma skin cancer

564

Cancer risk among patients with multiple sclerosis: A cohort study in Isfahan, Iran

565

Cancer risk analysis by fuzzy logic approach and performance status of the model

566

Cancer Risk Analysis of Benzene and Ethyl Benzene in Painters

567

Cancer risk and all-cause mortality among Norwegian military United Nations peacekeepers deployed to Kosovo between 1999 and 2011

568

Cancer risk and Barrett’s esophagus

569

Cancer Risk Assessment and the Genetic Counseling Process: Using Hereditary Breast and Ovarian Cancer as an Example

570

Cancer Risk Assessment Benzene, Toluene, Ethylbenzene and Xylene (BTEX) in the Production of Insulation Bituminous

571

Cancer Risk Assessment due to Accidental Exposure inside Neutron Laboratories using BEIR VII Model

572

Cancer risk assessment for Tehran research reactor and radioisotope laboratory with CAP88-PC code (Gaussian plume model)

573

Cancer Risk Assessment for Workers Exposed to Pollution Source, a Petrochemical Company, Iran

574

Cancer Risk Assessment From Multi-Exposure to Chloroform in Drinking Water of Ilam City, Iran

575

Cancer risk assessment from trihalomethanes in drinking water

576

Cancer Risk Assessment in Welder's Under Different Exposure Scenarios

577

Cancer risk assessment using blood dioxin levels and daily dietary TEQ intake in general populations of industrial and non-industrial countries

578

Cancer Risk Assessment: Evolution of the Process

579

Cancer Risk Assessment: Quality and Impact of the Family History Interview

580

Cancer Risk at Sites Other than the Breast Following Augmentation Mammoplasty

581

Cancer risk due to contamination: Consideration from market basket survey in Qatar

582

Cancer risk factors among men of diverse Hispanic or Latino origins

583

Cancer risk in endoscopically unresectable colon polyps

584

Cancer risk in hypertensive patients treated with calcium channel blockers

585

Cancer risk in menopausal women

586

Cancer risk in patients on dialysis

587

Cancer risk in patients on dialysis and after renal transplantation Original Research Article

588

Cancer risk in patients with monoclonal gammopathy of undetermined significance

589

Cancer risk models and preselection for screening

590

Cancer risk, hypertension, and antihypertensive medication

591

Cancer risks associated with the diagnosis of infertility

592

Cancer risks in children with congenital malformations in the nervous and circulatory system—A population based cohort study

593

Cancer screening among Latino subgroups in the United States

594

Cancer screening among older women in a culturally insular community

595

Cancer Screening Among the Overweight and Obese in Canada Original Research Article

596

Cancer screening and prevention practices of inner-city physicians

597

Cancer screening behaviors among smokers and non-smokers

598

Cancer Screening Benefits Maximization Using Markov Decision Process Models: A Systematic Review

599

Cancer screening estimates for U.S. metropolitan areas Original Research Article

600

Cancer Screening Guidelines: A Rapid Review

601

Cancer screening in end-stage renal disease

602

Cancer Screening in HMOs:: Program Development and Evaluation

603

Cancer screening in the elderly

604

Cancer Screening in Women: Body Mass Index and Adherence to Physician Recommendations Original Research Article

605

Cancer screening knowledge, attitudes, and behaviors among culturally Deaf adults: Implications for informed decision making

606

Cancer Screening Practice among Iranian Middleaged Women

607

Cancer screening practices among cancer survivors Original Research Article

608

Cancer screening with whole-body F-fluorodeoxyglucose positron-emission tomography

609

Cancer Screening, Effective or Harmful?

610

Cancer Screening, Effective or Harmful?

611

Cancer Screening: Knowledge, Attitudes, and Practices among Healthcare Personnel

612

Cancer Screening: Should Cancer Screening be Essential Component of Primary Health Care in Developing Countries?

613

Cancer self remission and tumor stability – a stochastic approach

614

Cancer should be prioritised on WHO agenda

615

Cancer Statistics in I.R. Iran in 2020

616

Cancer statistics: Current diagnosis and treatment of pancreatic cancer in Shanghai, China

617

Cancer stem cell biomarkers: critical roles, challenges, clinical applications and perspectives in cancer therapy

618

Cancer stem cell dynamics in tumor progression and metastasis: Is the microenvironment to blame?

619

Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter

620

Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma

621

Cancer stem cell markers in common cancers – therapeutic implications

622

Cancer stem cell, niche and EGFR decide tumor development and treatment response: A bio-computational simulation study

623

Cancer Stem Cell’s Potential Clinical Implications

624

Cancer Stem Cell’s Potential Clinical Implications

625

Cancer stem cells (CSCs): the blockage of metastatic and stemness properties by metal nanoparticles

626

Cancer Stem Cells and Oral Carcinogenesis; a Review Article

627

Cancer stem cells and telomerase as potential biomarkers in veterinary oncology

628

Cancer stem cells and tumor angiogenesis

629

Cancer stem cells as the engine of unstable tumor progression

630

Cancer stem cells CD133 and CD24 in colorectal cancers in Northern Iran

631

Cancer stem cells hypothesis and stem cells in head and neck cancers

632

Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective

633

Cancer stem cells in multiple myeloma

634

Cancer stem cells in urologic cancers

635

Cancer stem cells may drive growth of paediatric brain tumours

636

Cancer stem cells niche: A target for novel cancer therapeutics

637

Cancer stem cells sustaining the growth of mouse melanoma are not rare

638

Cancer stem cells, CD200 and immunoevasion

639

Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: Potential role of hypoxia

640

Cancer stem cells: A contentious hypothesis now moving forward

641

Cancer stem cells: Beyond Koch’s postulates

642

Cancer stem cells: emerging actors in both basic and clinical cancer research

643

Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty

644

Cancer stem cells: In the line of fire

645

Cancer stem cells: New therapeutic targets?

646

Cancer stem cells: potential target for bioactive food components

647

Cancer stem cells: Recent developments and future prospects

648

Cancer Stem Cells: Targets for treatment of malignancies to overcome drug resistance

649

Cancer stem cells: Toward novel anti-cancer therapies?

650

Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway

651

Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer

652

Cancer stromal targeting (CAST) therapy

653

Cancer surgery in the elderly—overall conclusions

654

Cancer surgery: the last 25 years

655

Cancer surveillance in Italian army peacekeeping troops deployed in Bosnia and Kosovo, 1996–2007: Preliminary results

656

Cancer survival

657

Cancer survival

658

Cancer survival as a function of age at diagnosis: A study of the Surveillance, Epidemiology and End Results database

659

Cancer survival classification using integrated data sets and intermediate information

660

Cancer survival in New Zealand: Ethnic, social and geographical inequalities

661

Cancer survival in patients with HIV/AIDS in the era of highly active antiretroviral therapy in Taiwan: A population-based cohort study

662

Cancer survival is no lottery

663

Cancer survival rates and GDP expenditure on health: a comparison of England and Wales and the USA, Denmark, Netherlands, Finland, France, Germany, Italy, Spain and Switzerland in the 1990s

664

Cancer Susceptibility and the Functions of BRCA1 and BRCA2

665

Cancer targeting strategies in nanomedicine: Design and application of chitosan nanoparticles

666

Cancer Terminologies Used in the Medieval Texts to the Early Modern Iranian Traditional Medicine (ITM)

667

Cancer theranostics: the rise of targeted magnetic nanoparticles

668

Cancer therapeutics in yeast

669

Cancer therapy with particle accelerators Original Research Article

670

Cancer therapy with phytochemicals: evidence from clinical studies

671

Cancer therapy: can the challenge be MET?

672

Cancer treatment by telomerase inhibitors: predictions by a kinetic model

673

Cancer treatment comes to age: from one-size-fits-all to next-generation sequencing (NGS) technologies

674

CANCER TREATMENT -OBJECTIVES AND QUALITY OF LIFE ISSUES

675

Cancer treatment reviews welcomes submission of the Cochrane Reviews

676

Cancer Treatment with the Alternative Herbal Medicine HUMA: Two Case Reports

677

Cancer treatment: the last 25 years

678

Cancer treatment-induced bone loss in premenopausal women: A need for therapeutic intervention?

679

Cancer Trends and the Importance of Prevention

680

Cancer trends in a province of Southwest of Iran, 2003–2016

681

Cancer tribe gathers

682

Cancer truth disclosure by Lebanese doctors

683

Cancer Tumor antigens

684

Cancer Turning in on death programs

685

Cancer types in dermatomyositis and polymyositis

686

Cancer types in dermatomyositis and polymyositis

687

Cancer Types in Pathological Samples Referred to Educational Hospitals in Birjand During the Past Three Years (2011 - 2013)

688

Cancer Types in Pathological Samples Referred to Educational Hospitals in Birjand During the Past Three Years (2011 - 2013).

689

Cancer Types in Pathological Samples Referred to Educational Hospitals in Birjand During the Past Three Years (2011-2013)

690

Cancer Types in Pathological Samples Referred to Educational Hospitals in Birjand During the Past Three Years (2011-2013)

691

Cancer vaccination progress

692

Cancer vaccines: a step towards prevention and treatment of cancer

693

Cancer vaccines: Harnessing the potential of anti-tumor immunity

694

Cancer Vulnerabilities Unveiled by Genomic Loss

695

Cancer warnings for West Bengalis drinking arsenic-contaminated water

696

Cancer Wars: How politics shapes what we know and donʹt know about cancer : Robert N. Proctor Basic Books, New York (1995) 356pp, indexes ISBN 0 465 02756 3 $25 hardback

697

Cancer wasting and quality of life react to early individualized nutritional counselling!

698

Cancer, A Big Monster, Which Should Be Defeated / The Editorial

699

Cancer, cancer cachexia, and diet: lessons from clinical research

700

Cancer, Chemotherapy, and Cor Pulmonale

701

Cancer, dépression et anxiété

702

Cancer, Somatic Mutation and Stem Cells

703

Cancer/radiothérapie

704

Cancer/testis antigens: A prospective reagent as diagnostic and immunotherapeutic targets for squamous cell carcinoma of the head and neck

705

Cancer/Testis genes in relation to sperm biology and function

706

Cancer: #1 The relationship of reproductive and body composition factors on the stage of cancer at diagnosis among non-hispanic white and hispanic postmenopausal breast cancer cases

707

Cancer: a lesson for us all

708

Cancer: A Systems Biology disease

709

Cancer: care or cure?

710

Cancer: Disease Caused by Alteration of Genes

711

Cancer: Editorial overview

712

Cancer: Editorial overview

713

Cancer: impact of nutrition intervention outcome—nutrition issues for patients

714

Cancer: Some genetic considerations

715

Cancer: Surviving on the edge

716

Cancer: The Future features in Iran

717

Cancer—a call for papers

718

Cancer—a call for papers

719

Cancer—a degenerative disorder?

720

Cancer-aociated Nummular Lo of the Pigment Epithelium

721

Cancer-aociated retinopathy aociated with invaive thymoma

722

Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner

723

Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner

724

Cancer-associated genodermatoses and familial cancer syndromes with cutaneous manifestations

725

Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy

726

Cancer-associated immune-mediated syndromes: Pathogenic values and clinical implementation

727

Cancer-Associated Mutations in BRC Domains of BRCA2 Affect Homologous Recombination Induced by Rad51

728

Cancer-associated thrombosis

729

Cancer-causing karyotypes: chromosomal equilibria between destabilizing aneuploidy and stabilizing selection for oncogenic function

730

cancer-curative potential of novel coumarins from watermelon princess: a scenario of their isolation and activity

731

Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up

732

Cancerous Tissue Diagnosis by LIF Spectroscopy Derived From Body-Compatible Fluorophores

733

Cancer-Preventive Effects of Drinking Green Tea among a Japanese Population,

734

Cancer-preventive isothiocyanates: dichotomous modulators of oxidative stress

735

Cancer-Preventive Selenocompounds Induce a Specific Redox Modification of Cysteine-Rich Regions in Ca2+- Dependent Isoenzymes of Protein Kinase C

736

Cancer-registry data in Latvia

737

Cancer-related fatigue: Links with inflammation in cancer patients and survivors

738

Cancer-related fears: A significant psychological burden in cancer patients and their caregivers

739

Cancer-related knowledge, attitudes, and behaviors among Chamorros on Guam

740

Cancer-Related Self-Efficacy in Iranian Women With Breast Cancer

741

Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis

742

Cancer-risk benefits of clean fuel technology and policy: A statistical analysis

743

Cancers after Renal Transplantation: Multicenter Experience

744

Cancers bronchiques non à petites cellules avec oligométastases : prise en charge chirurgicale à visée curative

745

Cancers bronchiques non à petites cellules de stade I : radiothérapie tridimensionnelle et radiothérapie en conditions stéréotaxiques

746

Cancers bronchiques non à petites cellules de stade I : radiothérapie tridimensionnelle et radiothérapie en conditions stéréotaxiques

747

Cancers bronchiques non à petites cellules localement évolués : curiethérapie de haut débit de dose complémentaire dʹune radiothérapie externe à visée curative

748

Cancers bronchiques non à petites cellules : amélioration des chances de survie par la radiothérapie conformationnelle ?

749

Cancers bronchiques non à petites cellules : facteurs prédictifs de survenue de pneumopathie radique

750

Cancers bronchiques non à petites cellules : facteurs prédictifs de survenue de pneumopathie radique

751

Cancers bronchiques non à petites cellules : facteurs prédictifs de survenue de pneumopathie radique

752

Cancers bronchiques traités par irradiation tridimensionnelle : influence de la délinéation pulmonaire en mode automatique seul ou en mode automatique excluant le volume cible prévisionnel

753

Cancers bronchiques traités par irradiation tridimensionnelle : influence de la délinéation pulmonaire en mode automatique seul ou en mode automatique excluant le volume cible prévisionnel

754

Cancers bronchiques : la radiothérapie prophylactique des aires ganglionnaires a-t-elle encore une place ?

755

Cancers bronchopulmonaires chez le sujet jeune

756

Cancers bronchopulmonaires chez le sujet jeune

757

Cancers de l’amygdale : peut-on ne pas irradier les patients en situation de bonne réponse à la chimiothérapie d’induction ?

758

Cancers de l’amygdale : peut-on ne pas irradier les patients en situation de bonne réponse à la chimiothérapie d’induction ?

759

Cancers de la cavité buccale : à propos de 145 cas à l’institut Joliot-Curie de Dakar

760

Cancers de la cavité buccale : à propos de 145 cas à l’institut Joliot-Curie de Dakar

761

Cancers de la prostate

762

Cancers de la tête et du cou

763

Cancers de prostate : le traitement local par irradiation a-t-il un impact sur la survie ?

764

Cancers de prostate : quelle place pour la radiothérapie à visée curative chez les patients âgés ?

765

Cancers de prostate : quelles techniques de radiothérapie pour quelles tumeurs ? Enjeux éthiques et méthodologiques

766

Cancers de VADS

767

Cancers des voies aérodigestives supérieures : bénéfices cliniques de la radiothérapie conformationnelle et de la modulation d’intensité

768

Cancers des voies aérodigestives supérieures : le retour de la chimiothérapie néoadjuvante ?

769

Cancers du foie et des voies biliaires

770

Cancers du nasopharynx chez l’enfant et l’adolescent : aspects particuliers

771

Cancers du nasopharynx chez l’enfant et l’adolescent : aspects particuliers

772

Cancers du poumon non à petites cellules

773

Cancers du rectum : la chimioradiothérapie préopératoire, nouveau standard

774

Cancers du rectum : volumes cible de la radiothérapie, bases rationnelles

775

Cancers du sein après radiothérapie : facteurs de risque et proposition de définition du sein chez la jeune fille prépubère comme organe à risque

776

Cancers du sein après radiothérapie : facteurs de risque et proposition de définition du sein chez la jeune fille prépubère comme organe à risque

777

Cancers du sein de petit stade : la radiothérapie exclusive est-elle une option en cas de réponse clinique complète à la chimiothérapie néoadjuvante ?

778

Cancers du sein de petit stade : la radiothérapie exclusive est-elle une option en cas de réponse clinique complète à la chimiothérapie néoadjuvante ?

779

Cancers du sein de stade II-IIIA : la radiothérapie exclusive est-elle une option en cas de réponse clinique complète à la chimiothérapie néoadjuvante ?

780

Cancers du sein localement évolués (T3-T4b) avec curage ganglionnaire négatif (sans chimiothérapie néoadjuvante) : profil évolutif et facteurs pronostiques

781

Cancers du sein localement évolués (T3-T4b) avec curage ganglionnaire négatif (sans chimiothérapie néoadjuvante) : profil évolutif et facteurs pronostiques

782

Cancers du sein radio-induits présentant des caractéristiques anatomopathologiques agressives : étude rétrospective du comité de suivi à long terme de la Société française des cancers de l’enfant

783

Cancers du sein radio-induits présentant des caractéristiques anatomopathologiques agressives : étude rétrospective du comité de suivi à long terme de la Société française des cancers de l’enfant

784

Cancers du sein : comment associer l’hormonothérapie et la radiothérapie en situation adjuvante ?

785

Cancers of the blood from benzene

786

Cancers of the Brain and CNS: Global Patterns and Trends in Incidence

787

Cancers of the salivary gland: Workplace risks among women and men

788

Cancers of the Upper Gastro-intestinal Tract: A Review of Somatic Mutation Distributions

789

Cancers of Urinary System; Prevalence, Demographic

790

Cancers primitifs invasifs de la vulve : expérience de l’Institut national d’oncologie de Rabat

791

Cancers primitifs invasifs de la vulve : expérience de l’Institut national d’oncologie de Rabat

792

Cancers radio-induits: le point en 1997

793

Cancers rectocoliques chez le sujet de moins de 40 ans

794

Cancers secondaires ou seconds cancers ?

795

Cancers secondaires ou seconds cancers ?

796

Cancerʹs sweet tooth

797

Cancerʹs sweet tooth: the Janus effect of glucose metabolism in tumorigenesis

798

Cancers, Mainly Male, as Population Biomarkers for Breast Cancer Mortality

799

Cancer-specific chemoprevention and anti-metastatic potentials of Rheum emodi rhizome ethyl acetate extracts and identification of active principles through HPLC and GC-MS analysis

800

Cancer-testis antigen, BORIS based vaccine delivered by dendritic cells is extremely effective against a very aggressive and highly metastatic mouse mammary carcinoma

801

Cancْn following Copenhagen

802

Cancrinite and sodalite formation in the presence of cesium, potassium, magnesium, calcium and strontium in Hanford tank waste simulants

803

804

805

Cancrum oris and noma: some etymological and historical remarks

806

Cancrum oris: its incidence and treatment in Enugu, Nigeria

807

Cancun 2002: The role of nanomaterials in solar energy conversion

808

Cand1 Promotes Assembly of New SCF Complexes through Dynamic Exchange of F Box Proteins

809

Candelabra systems and designs

810

Candesartan and heart failure: the allure of CHARM

811

Candesartan Attenuates Ischemic Brain Edema and Protects the Blood–Brain Barrier Integrity from Ischemia/Reperfusion Injury in Rats

812

Candesartan cilexetil and renal hemodynamics in hypertensive patients

813

Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertension

814

Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough

815

Candesartan improves myocardial damage in obese mice with viral myocarditis and induces cardiac adiponectin

816

Candesartan in the prevention of relapsing atrial fibrillation

817

CANDESARTAN TREATMENT RESTORES DIABETES-INDUCED CHANGES IN [CA2+]I TRANSIENTS OF CARDIOMYOCYTES

818

Candesartan-Based Therapy and Risk of Cancer in Patients With Systemic Hypertension (Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease [HIJ-CREATE] Substudy)

819

Candi Sungai Batu (Tapak SB1): Kearifan Tempatan dalam Teknologi Pembuatan Bata dan Seni Bina Candi

820

Candid “confessions” of an editor: prioritizing journal space when increased submissions have led to publication backlog

821

Candid candidate comments: The relationship between residency program selection factors and match list placements from ranked applicants

822

Candid covariance-free incremental principal component analysis

823

Candida Albicans Activated Splenocytes Promote Strong Immune Responses in a Murine Model of Breast Cancer

824

Candida albicans adherence on silicone elastomers: Effect of polymerisation duration and exposure to simulated saliva and nasal secretion

825

Candida albicans Adherence to Glass Ionomer Restorative Dental Material

826

Candida albicans and HTV-1 Infection

827

Candida albicans cell wall comprises a branched β-d-(1→6)-glucan with β-d-(1→3)-side chains Original Research Article

828

Candida albicans depress cardiovascular function of rabbit

829

Candida Albicans detection in pre-malignant and malignant lesions of the oral cavity

830

Candida albicans endophthalmitis after anabolic steroid abuse

831

Candida albicans infection enhances immunosuppression induced by cyclophosphamide by selective priming of suppressive myeloid progenitors for NO production

832

Candida albicans mannan- and protein-induced humoral, cellular and cytokine responses in atopic dermatitis patients

833

Candida albicans Release Intracellular Bacteria When Treated With Amphotericin B

834

Candida albicans Structural and Secreted Proteins Modulate CD4/CD8 Ratio in Tumor Infiltrating Lymphocytes of Spontaneous Adenocarcinoma Bearing Mice

835

Candida albicans suppresses nitric oxide (NO) production by interferon-gamma (IFN - gamma) and lipopolysaccharide (LPS)-stimulated murine peritoneal macrophages

836

Candida albicansNucleoside-Diphosphate Kinase: Purification and Characterization

837

Candida antarctica lipase A and Pseudomonas stutzeri lipase as a pair of stereocomplementary enzymes for the resolution of 1,2-diarylethanols and 1,2-diarylethanamines

838

Candida antarctica Lipase B Immobilization Onto Hybrid Organic-inorganic Mesoporous Materials

839

Candida antarctica lipase B-catalyzed reactions of β-hydroxy esters: Competition of acylation and hydrolysis

840

Candida antarctica lipase B-catalyzed synthesis of acetamides using [BMIm(PF6)] as a reaction medium

841

Candida antarctica lipase B-catalyzed the unprecedented three-component Hantzsch-type reaction of aldehyde with acetamide and 1,3-dicarbonyl compounds in non-aqueous solvent

842

Candida antarctica lipases acting as versatile catalysts for the synthesis of enantiopure (R)- and (S)-1-(2-phenylthiazol-4-yl)ethanamines

843

Candida Antigen Titer Elevation and Mortality in Burn Patients

844

Candida auris and COVID-19: A health threatening combination

845

Candida auris emergence in the Himalayan foothills: First case report from Uttarakhand, India

846

Candida auris in a tertiary healthcare setting in south India: A case series

847

Candida auris: A New Emerging Fungal Monster

848

Candida auris: outbreak fungal pathogen in COVID-19 pandemic: a systematic review and meta-analysis

849

candida berkh. (1923) species and their important secreted aspartyl proteinases (sap) genes isolated from diabetic patients

850

Candida Bloodstream Infection: Changing Pattern of Occurrence and Antifungal Susceptibility over 10 Years in a Tertiary Care Saudi Hospital

851

Candida Carriage Rate and Growth Characteristics of Saliva in Diabetes Mellitus Patients: A Case-Control Study

852

Candida cloacae oxidation of long-chain fatty acids to dioic acids

853

Candida colonisation within a silicone tissue expander

854

Candida Colonization in Low Birth Weight and Very Low Birth Weight Infants in a Neonatal Intensive Care Unit

855

Candida colonization of the esophagus and gastric mucosa; a comparison of patients taking proton pump inhibitors and those taking histamine receptor antagonist drugs

856

Candida Colonization on the Denture of Diabeticand Non-diabetic Patients

857

Candida Colonization on the Denture of Diabeticand Non-diabetic Patients

858

Candida commensalism and virulence: the evolution of phenotypic plasticity

859

Candida dubliniensis: A rare cause of nail infection

860

Candida glabrata oropharyngeal infection in a patient with oral squamous cell carcinoma after COVID-19 infection

861

Candida Glabrata: An emerging threat for the Immunocompromised

862

Candida glabrata: Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison to C. albicans

863

Candida humilis—dominant species in sourdoughs for the production of durum wheat bran flour bread

864

Candida Infection in a Stent Inserted for Tracheal Stenosis After Heart Lung Transplantation

865

Candida infections among neutropenic patients

866

Candida infections: Novel virulence factors and mechanisms of azole resistance

867

Candida isolates from pregnant women and their antifungal susceptibility in a Malaysian tertiary-care hospital

868

Candida isolation from peritoneal fluid: Its role in the outcome of patients with perforation peritonitis

869

Candida krusei development on turbulent flow regimes: Biofilm formation and efficiency of cleaning and disinfection program Original Research Article

870

Candida laryngitis appearing as carcinoma

871

Candida lung abscesses in a renal transplant recipient

872

Candida parapsilosis as a Potent Biocontrol Agent against Growth and Aflatoxin Production by Aspergillus Species

873

Candida parapsilosis endocarditis 8 months after transient candidemia

874

Candida pericarditis: A rare case report

875

Candida Pericarditis: Clinical Profile and Treatment

876

Candida rugosa lipase immobilized by a specially designed microstructure in the PVA/PTFE composite membrane

877

Candida rugosa lipase Lip1–polyethyleneglycol interaction and the relation with its partition in aqueous two-phase systems

878

Candida rugosa lipase mediated multigram synthesis of acid part of S(+)-atliprofen, a new NSAID and molecular modeling studies aimed at predicting selectivity of the enzyme

879

Candida Rugosa lipase reactions in nonionic w/o-microemulsion with a technical surfactant

880

Candida rugosa lipase-catalyzed enantioselective hydrolysis in organic solvents. Convenient preparation of optically pure 2-hydroxy-2-arylethanephosphonates

881

Candida Rugosa lipase-catalyzed kinetic resolution of β-hydroxy-β-arylpropionates and δ-hydroxy-δ-aryl-β-oxo-pentanoates

882

Candida sepsis in surgery

883

Candida species in cutaneous candidiasis patients in the Guilan province in Iran; identified by PCR-RFLP method.

884

Candida species isolated from clinical samples in a tertiary hospital in Honduras: Where is Candida auris?

885

Candida Species Isolated from Various Clinical Samples and Their Susceptibility Patterns to Antifungals

886

Candida theae sp. nov., a new anamorphic beverage-associated member of the Lodderomyces clade

887

Candida tropicalis chorioamnionitis

888

Candida tropicalis osteomyelitis: Case report and review of literature

889

Candida Urinary Tract Infection Among ICU Patients in Isfahan, Iran

890

Candida utilis assimilates oligomeric sugars in rice straw hydrolysate via the Calcium-Capturing-by-Carbonation (CaCCO) process for glutathione- and cell-biomass production

891

Candidacidal Action of CF66I, an Antifungal Compound Produced by Burkholderia Cepacia

892

Candidacidal activities of the glucose oxidase-mediated lactoperoxidase system

893

Candidacy for active surveillance may be associated with improved functional outcomes after prostatectomy

894

Candidacy for active surveillance may be associated with improved functional outcomes after prostatectomy

895

Candidaemia secondary to intravascular catheter colonisation?

896

Candidaemia secondary to intravascular catheter colonisation? – Authorsʹ reply

897

Candidal Leukoplakia on Patient with Removable Denture

898

Candidate 56 and 58 kDa protein(s) responsible for mediating the renal defects in oncogenic hypophosphatemic osteomalacia

899

Candidate ability and platform choice

900

Candidate AIDS vaccine inspires hope

901

Candidate antiretroviral agents for use in postexposure prophylaxis

902

Candidate biomarker discovery in plasma of juvenile cod (Gadus morhua) exposed to crude North Sea oil, alkyl phenols and polycyclic aromatic hydrocarbons (PAHs)

903

Candidate Biomarkers for Targeting in Type 1 Diabetes; A Bioinformatic Analysis of Pancreatic Cell Surface Antigens

904

Candidate blanket concepts for a European fusion power plant study

905

Candidate bone-tissue-engineered product based on human-bone-derived cells and polyurethane scaffold

906

Candidate chiral band in 134La Original Research Article

907

Candidate chromosome 1 disease susceptibility genes for Sjogrenʹs syndrome xerostomia are narrowed by novel NOD.B10 congenic mice

908

Candidate Defense Genes from Rice, Barley, and Maize and Their Association with Qualitative and Quantitative Resistance in Rice

909

Candidate eco-labeling and senate campaign contributions

910

Candidate Gender and Electoral Success in Single Transferable Vote Systems

911

Candidate Gene Analysis for Quantitative Traits Using the Transmission Disequilibrium Test: The Example of the Melanocortin 4-Receptor in Pigs

912

Candidate Gene Association Study of Coronary Artery Calcification in Chronic Kidney Disease: Findings From the CRIC Study (Chronic Renal Insufficiency Cohort)

913

Candidate gene expression associated with geographical variation in cryoprotective dehydration of Megaphorura arctica

914

Candidate gene marker associations with fatty acid profiles in heavy pigs

915

Candidate gene markers associated with somatotropic axis and milk selection

916

Candidate gene markers for sperm quality and fertility of boar

917

Candidate gene markers involved in San Daniele ham quality

918

Candidate Gene Polymorphism for IL-Ry and ChB6 Genes in the Indigenous Chicken of North Western Himalayan State of Himachal Pradesh, India

919

Candidate gene polymorphisms and the 9p21 locus in acute coronary syndromes

920

Candidate gene polymorphisms in solid cancers

921

Candidate Gene Polymorphisms in the Serotonergic Pathway: Influence on Depression Symptomatology in an Elderly Population

922

Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease

923

Candidate genes affecting sheep and goat milk quality

924

Candidate genes and a genome-wide search in Italian families with atopic asthmatic children

925

Candidate genes contributing to the aggressive phenotype of mantle cell lymphoma

926

Candidate genes for behavioural ecology

927

Candidate genes for milk production traits in Portuguese dairy sheep

928

Candidate genes for physical performance in the horse

929

Candidate genes for resistance to Salmonella enteritidis colonization in chickens as detected in a novel genetic cross

930

Candidate genes for resistance to Salmonella enteritidis colonization in chickens as detected in a novel genetic cross

931

Candidate genes in the osteocyte response to mechanical loading in vivo

932

Candidate Genes Polymorphism and Its Association to Prolificacy in Chinese Goats

933

Candidate hypertension-related phenotypes

934

CANDIDATE ISOLATED NEUTRON STARS AND OTHER OPTICALLY BLANK X-RAY FIELDS IDENTIFIED FROM THE ROSAT ALL-SKY AND SLOAN DIGITAL SKY SURVEYS

935

Candidate markers for thromboembolic complications in adult Egyptian patients with β-thalassemia

936

Candidate mechanisms controlling the electrical characteristics of silica/XLPE nanodielectrics

937

Candidate mediators of chondrocyte mechanotransduction via targeted and untargeted metabolomic measurements

938

Candidate Molecular Biomarkers for the Non- Invasive Detection of Colorectal Cancer using Gene Expression Profiling

939

Candidate Notification Scale for Gifted Children in Pre-school Period: Validity and Reliability Studies

940

Candidate Positioning and Entry in a Political Competition

941

Candidate pruning for fast corner detection

942

Candidate quality of care indicators for localized bladder cancer

943

Candidate quality, pressure group endorsements and the nature of political advertising

944

Candidate reactions for mercury detection induced by neutron and alpha particles

945

Candidate reactions for mercury detection induced by neutron and alpha particles

946

Candidate regions of tumor suppressor gene by loss of heterozygosity analysis on chromosome 8p11.1–q13.3 in gastric cancer

947

Candidate tumor suppressor gene SLC5A8 is frequently down-regulated by promoter hypermethylation in prostate tumor

948

CANDIDATE VALENCE: EVIDENCE FROM CONSECUTIVE PRESIDENTIAL ELECTIONS∗

949

Candidate waste forms for immobilisation of waste chloride salt from pyroprocessing of spent nuclear fuel

950

Candidate wasteforms for the immobilization of chloride-containing radioactive waste

951

Candidate working set strategy based SMO algorithm in support vector machine

952

Candidates for Novel RNA Topologies

953

Candidates for therapy: HBV

954

Candidates for U-lines at 1377 and 1394 MHz in IRC+10216: ab initio molecular orbital study

955

Candidates of low-lying dibaryons with strangeness s⩽−5 in a symmetry analysis

956

Candidates’ negotiation of their expertise in job interviews

957

Candidature of equal channel angular pressing for processing of tubular commercial purity-titanium

958

Candidatus Phytoplasma asterisʹ isolate associated with a little leaf disease of pigeon pea in India

959

Candidemia and its Risk Factors in Neonates and Children

960

Candidemia due to Candida guilliermondii in an immuno-compromised infant: a case report and review of literature

961

Candidemia in Children Caused by Uncommon Species of Candida

962

Candidemia in Febrile Neutropenic Patients; a Brief Report

963

Candidemia in patients with prolonged fever in Kashan, Iran

964

Candidemia in pediatric burn patients: Risk factors and outcomes in a retrospective cohort study

965

Candidemia in the Neonatal Intensive Care Unit: Insights on Epidemiology and Antifungal Drug Susceptibility Patterns

966

Candidemia: Changing dynamics from a tertiary care hospital in North India

967

Candidiasis in breast cancer: Tumor progression or not?

968

Candidiasis in Pediatrics; Identification and In vitro Antifungal Susceptibility of the Clinical Isolates

969

Candidose oropharyngée et radiothérapie

970

Candiduria in Hospitalized Patients and Identification of Isolated Candida Species by Morphological and Molecular Methods in Ilam, Iran

971

Candiduria in hospitalized patients in teaching hospitals of Ahvaz

972

Candiduria: A Review of Clinical Significance and Management

973

Candiduria: Prevalence, Identification of Isolated Candida Species and Trends in Antifungal Susceptibility in Hospitalized Patients

974

Candies in hell: women’s experiences of violence in Nicaragua

975

CANDLE: The New Burnup Strategy

976

Candle-based process for creating a stable superhydrophobic surface

977

CANDU fuel bundle deformation modelling with COMSOL multiphysics

978

CANDU fuel management optimization using alternative gradient methods

979

CANDU reactor as minor actinide/thorium burner with uniform power density in the fuel bundle

980

CANDU reactor core simulations using fully coupled DRAGON and DONJON calculations

981

CANDU REACTOR SIMULATIONS USING THE FEEDBACK MODEL WITH ACTINIDE BURNUP HISTORY

982

CANDU steam generator life management

983

CANDU steam generator life management

984

Candu type fuel behavior during rapid overpower transients Original Research Article

985

Candu® NPP reactor regulating system modelling using CATHENA

986

CANDU-6 operation post-simulations using the reactor physics codes DRAGON/DONJON

987

CANDUtechnologyforGenerationIII+andIVreactorsOriginalResearchArticle

988

Candy or apple? How self-control resources and motives impact dietary healthiness in women

989

Cane Contracting and Renegotiation: A Fixed Effects Analysis of the Adoption of New Technologies in the Cuban Sugar Industry, 1899-1929

990

Cane juice quality variation at different sampling locations

991

Cane molasses as a source of precursors in the bioproduction of tryptophan by Bacillus subtilis.

992

Canebrake Rattlesnake Envenomation, ,

993

Cangrelor bridging strategy for liver damage after mechanical chest compression

994

Canidae volume bone mineral density values: an application to sites in western Canada

995

Canine and Feline Geriatric Oncology: Honoring the Human–Animal Bond, first ed., A. Villalobos, L. Kaplan. Blackwells Publishing (2007), ISBN: 9780-813802664

996

Canine and feline intracranial meningiomas: An updated review

997

Canine atopic dermatitis in Greece: clinical observations and the prevalence of positive intradermal test reactions in 91 spontaneous cases

998

Canine atopic dermatitis in Greece: clinical observations and the prevalence of positive intradermal test reactions in 91 spontaneous cases

999

Canine atopic disease: the prevalence of positive intradermal skin tests at two sites in the north and south of Great Britain

1000

Canine atopic disease: the prevalence of positive intradermal skin tests at two sites in the north and south of Great Britain

بازگشت